Cargando…
Do fluoroquinolones actually increase mortality in community-acquired pneumonia?
Autor principal: | Agarwal, Ritesh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550836/ https://www.ncbi.nlm.nih.gov/pubmed/16469131 http://dx.doi.org/10.1186/cc3989 |
Ejemplares similares
-
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia
por: Covington, Paul S., et al.
Publicado: (2013) -
Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006) -
Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
por: Shen, Gwan-Han, et al.
Publicado: (2012) -
Clinicomicrobiological study of community-acquired pneumonia
por: Prasad, Prashasti, et al.
Publicado: (2017) -
Non-Adherence in Adult Male Patients with Community-Acquired Pneumonia: Relative Forgiveness of Amoxicillin versus Respiratory Fluoroquinolones
por: Carral, Nerea, et al.
Publicado: (2023)